phase ii trial of bomedemstat for advanced myelofibrosis
Published 3 years ago • 134 plays • Length 7:42Download video MP4
Download video MP3
Similar videos
-
2:41
bomedemstat combined with ruxolitinib for the treatment of mf: early results of a phase ii trial
-
7:10
bomedemstat in jak inhibitor-resistant myelofibrosis
-
1:58
novel myelofibrosis-associated anemia treatments in phase ii trials
-
1:19
telomerase inhibition as a novel targeted therapy for myelofibrosis
-
5:00
long-term results of the phase ii revive study evaluating rusfertide in patients with pv
-
2:04:33
01-diagnosis and management of marginal zone lymphomas
-
7:26
clinical decision making processes typical to health professionals
-
1:08
irl6372trpbf-vb is a 2 n-channel sop8 package mos tube
-
1:37
a phase ii trial evaluating e7820 in patients with aml with splicing factor mutations
-
1:25
the current approach to managing patients with prefibrotic pmf
-
4:22
accelerated-phase mpns: pathophysiology, treatment approaches and ongoing clinical trials
-
4:39
imetelstat shows promise in advanced myelofibrosis
-
3:35
new phase iii trial of imetelstat versus bat in jak inhibitor-refractory myelofibrosis
-
3:20
safety run-in of a phase ii trial of cpx-351 plus pomalidomide in aml with mds-related changes
-
2:51
bomedemstat for high-risk myelofibrosis
-
5:13
phase ii trial of pembrolizumab prior to allo-sct in aml
-
1:30
results of the ruxopeg trial: combining ruxolitinib and interferon in patients with myelofibrosis
-
1:17
phase ii study of tosedostat in mds
-
1:52
phase i dose-escalation study of the bet inhibitor incb057643 in r/r myelofibrosis
-
1:02
a phase ii single-arm study of obinutuzumab plus ibrutinib as frontline treatment for fl and mzl
-
2:19
insights into the phase iia mylox-1 trial: assessing efficacy of gb2064 in myelofibrosis